Serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae causing invasive disease in Scotland, 1999–2002

References

1. Bos J. M., Rumke H., Welte R., Postma M. J. 2003; Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands. Clin Ther 25:2614–2630 [CrossRef]
   [Google Scholar]
2. Clarke S. C., Diggle M. A., Edwards G. F. 2001; Surveillance of pneumococcal disease in Scotland. SCIEH Weekly Report 35:2– 2
   [Google Scholar]
3. Gertz R. E. Jr, McEllistrem M. C., Boxrud D. J. & 8 other authors; 2003; Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 41:4194–4216 [CrossRef]
   [Google Scholar]
4. Kyaw M. H., Clarke S., Edwards G. F., Jones I. G., Campbell H. 2000; Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies. Epidemiol Infect 125:561–572 [CrossRef]
   [Google Scholar]
5. Kyaw M. H., Jones I. G., Campbell H. 2002a; Prevalence of penicillin non-susceptible invasive pneumococcal disease in the elderly in Scotland, 1992–99. Scand J Infect Dis 34:559–563 [CrossRef]
   [Google Scholar]
6. Kyaw M. H., Clarke S., Jones I. G., Campbell H. 2002b; Incidence of invasive pneumococcal disease in Scotland, 1988–99. Epidemiol Infect 128:139–147
   [Google Scholar]
7. Kyaw M. H., Christie P., Clarke S. C., Mooney J. D., Ahmed S., Jones I. G., Campbell H. 2003; Invasive pneumococcal disease in Scotland, 1999–2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 37:1283–1291 [CrossRef]
   [Google Scholar]
8. Mohan P. V., Heath P. T. 2001; Pneumococcal disease in childhood. Hosp Med 62:406–409 [CrossRef]
   [Google Scholar]
9. Muhlemann K., Matter H. C., Tauber M. G., Bodmer T. 2003; Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998–1999. J Infect Dis 187:589–596 [CrossRef]
   [Google Scholar]
10. Obaro S., Adegbola R. 2002; The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol 51:98–104
    [Google Scholar]
11. Skoczynska A., Hryniewicz W. 2003; Genetic relatedness, antibiotic susceptibility, and serotype distribution of Streptococcus pneumoniae responsible for meningitis in Poland, 1997–2001. Microb Drug Resist 9:175–182 [CrossRef]
    [Google Scholar]
12. Smart L. E. 1986; Serotyping of Streptococcus pneumoniae strains by coagglutination. J Clin Pathol 39:328–331 [CrossRef]
    [Google Scholar]
13. Whitney C. G., Farley M. M., Hadler J. & 10 other authors; 2003; Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine. N Engl J Med 348:1737–1746 [CrossRef]
    [Google Scholar]